A detailed history of Diversified Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 1,207 shares of REGN stock, worth $874,918. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,207
Previous 1,209 0.17%
Holding current value
$874,918
Previous $1.27 Million 0.16%
% of portfolio
0.04%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$1024.09 - $1201.76 $2,048 - $2,403
-2 Reduced 0.17%
1,207 $1.27 Million
Q2 2024

Jul 16, 2024

BUY
$883.2 - $1071.19 $19,430 - $23,566
22 Added 1.85%
1,209 $1.27 Million
Q1 2024

Apr 18, 2024

BUY
$902.69 - $993.35 $16,248 - $17,880
18 Added 1.54%
1,187 $1.14 Million
Q4 2023

Jan 08, 2024

SELL
$775.18 - $881.7 $160,462 - $182,511
-207 Reduced 15.04%
1,169 $1.03 Million
Q3 2023

Nov 17, 2023

BUY
$692.45 - $844.37 $5,539 - $6,754
8 Added 0.58%
1,376 $1.13 Million
Q2 2023

Jul 18, 2023

BUY
$700.03 - $830.35 $9,800 - $11,624
14 Added 1.03%
1,368 $982,000
Q1 2023

Apr 07, 2023

BUY
$680.49 - $826.97 $23,817 - $28,943
35 Added 2.65%
1,354 $1.11 Million
Q4 2022

Jan 17, 2023

SELL
$705.89 - $766.39 $4,941 - $5,364
-7 Reduced 0.53%
1,319 $952,000
Q3 2022

Oct 14, 2022

SELL
$573.97 - $724.32 $21,810 - $27,524
-38 Reduced 2.79%
1,326 $913,000
Q2 2022

Jul 12, 2022

BUY
$548.35 - $738.84 $27,965 - $37,680
51 Added 3.88%
1,364 $806,000
Q1 2022

Apr 07, 2022

SELL
$595.12 - $698.43 $191,033 - $224,196
-321 Reduced 19.65%
1,313 $917,000
Q4 2021

Jan 13, 2022

SELL
$543.48 - $670.97 $34,782 - $42,942
-64 Reduced 3.77%
1,634 $1.03 Million
Q3 2021

Jan 13, 2022

BUY
$574.03 - $680.96 $65,439 - $77,629
114 Added 7.2%
1,698 $1.03 Million
Q2 2021

Jul 20, 2021

SELL
$472.8 - $558.54 $251,056 - $296,584
-531 Reduced 25.11%
1,584 $885,000
Q1 2021

May 10, 2021

BUY
$446.73 - $548.2 $381,060 - $467,614
853 Added 67.59%
2,115 $1 Million
Q4 2020

Jan 08, 2021

BUY
$478.3 - $607.98 $103,312 - $131,323
216 Added 20.65%
1,262 $610,000
Q3 2020

Oct 15, 2020

BUY
$544.75 - $658.21 $167,238 - $202,070
307 Added 41.54%
1,046 $586,000
Q2 2020

Jul 07, 2020

SELL
$493.32 - $643.92 $4,933 - $6,439
-10 Reduced 1.34%
739 $461,000
Q1 2020

Apr 10, 2020

BUY
$336.18 - $494.43 $4,706 - $6,922
14 Added 1.9%
749 $366,000
Q4 2019

Jan 09, 2020

BUY
$274.13 - $376.51 $201,485 - $276,734
735 New
735 $276,000
Q1 2019

May 22, 2019

SELL
$372.08 - $439.57 $1.35 Million - $1.6 Million
-3,630 Closed
0 $0
Q4 2018

Jan 18, 2019

BUY
$335.82 - $403.04 $10,074 - $12,091
30 Added 0.83%
3,630 $1.36 Million
Q2 2018

Jul 23, 2018

SELL
$284.6 - $344.99 $1,423 - $1,724
-5 Reduced 0.14%
3,600 $1.24 Million
Q3 2017

Oct 17, 2017

BUY
$431.38 - $504.0 $1.56 Million - $1.82 Million
3,605
3,605 $1.61 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.